Work

Supplemenatry Figure S7 from PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer

Year: 2023

Type: other

Abstract: (A) TMA2 WEE1 and PAXIP1 staining, breakdown by KRAS mutation and WEE1/PAXIP1 staining status. (B) TMA3 - WEE1 and PAXIP1 staining.

DOI: 10.1158/1535-7163.22507993.v1

Authors: Ankita Jhuraney, Nicholas T. Woods, Gabriela Wright, Lily Rix, Fumi Kinose, Jodi L. Kroeger, Elizabeth Remily-Wood, W. Douglas Cress, John M. Koomen, Stephen G. Brantley, Jhanelle E. Gray, Eric B. Haura, Uwe Rix, Alvaro N. Monteiro

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362535451

Cites:

Cited by:

Related to: 10